Serotonin 5-HT1E Receptor Neurons represent a unique population of neurons expressing the 5-hydroxytryptamine 1E (5-HT1E) receptor, a Gi protein-coupled receptor (GPCR) that was historically referred to as an "orphan" receptor due to its initially uncertain endogenous ligand [@burger]. The 5-HT1E receptor is encoded by the HTR1E gene and is expressed in select brain regions, particularly the olfactory bulb, cerebral cortex, and hippocampus [@xue]. Unlike other 5-HT1 family members, the 5-HT1E receptor exhibits unusual pharmacological properties and signaling mechanisms that have made it a subject of significant research interest. Recent evidence suggests that these neurons may play important roles in cognitive function, mood regulation, and neuropsychiatric disorders including major depressive disorder, bipolar disorder, and schizophrenia [@gaddam]. Additionally, the receptor's ability to modulate neurotransmitter release, particularly dopamine, positions it as a potential therapeutic target in neurodegenerative diseases.
The 5-HT1E receptor has a somewhat confusing history in serotonin receptor classification:
Initial discovery: The receptor was first identified through radioligand binding studies in the 1980s, but its pharmacological profile did not match any known serotonin receptor.
Orphan receptor status: For several years, it was classified as an "orphan" receptor (initially termed 5-HT1E) because its endogenous ligand was uncertain [@burger].
Reclassification: Subsequent studies confirmed that serotonin does bind to this receptor with moderate affinity (Kd ≈ 3-10 nM), leading to its official designation as 5-HT1E.
Species differences: Notably, rodent and human 5-HT1E receptors show significant pharmacological differences, complicating preclinical research translation.
The 5-HT1E receptor shares the seven-transmembrane domain architecture typical of Class A GPCRs:
| Feature | Details |
|---|---|
| Gene | HTR1E |
| Chromosomal location | 6q14.1 (human) |
| Amino acids | 365 (human) |
| Molecular weight | ~41 kDa |
| Key residues | Asp Arg Tyr at positions 82, 131, 374 (conserved in 5-HT1 family) |
The 5-HT1E receptor demonstrates several unique signaling characteristics that distinguish it from other 5-HT1 family members:
G protein coupling paradox: Initial studies in Sf9 cells suggested the 5-HT1E receptor did not couple efficiently to G-proteins [@hamblin]. However, subsequent research in mammalian cells demonstrated clear Gi/o protein coupling.
Dual G protein coupling: Uniquely among 5-HT1 receptors, 5-HT1E can couple to both Gi (inhibitory) and Gs (stimulatory) proteins depending on cellular context [@yuen]. This "biased signaling" allows for complex modulation of cellular responses.
PI pathway activation: In cortical neurons, 5-HT1E receptor activation can stimulate the phosphoinositide (PI) pathway through Gq protein coupling, leading to phospholipase C activation and subsequent intracellular calcium release [@schmid].
B-arrestin recruitment: Modern research indicates 5-HT1E can also signal through β-arrestin-dependent pathways, providing additional mechanisms for cellular modulation.
The 5-HT1E receptor exhibits a distinctive pattern of expression in the human and rodent brain:
| Brain Region | Expression Level | Functional Implication |
|---|---|---|
| Olfactory bulb | Very high | Olfactory processing, neurogenesis |
| Cerebral cortex | High | Cognitive functions, working memory |
| Hippocampus | Moderate-High | Learning, memory, mood regulation |
| Dorsal raphe nucleus | Low-Moderate | Autoreceptor function |
| Striatum | Low-Moderate | Motor control, habit formation |
| Amygdala | Low | Emotional processing |
| Hypothalamus | Low | Homeostatic regulation |
Within these regions, 5-HT1E receptors are found on both neurons and glial cells:
Autoradiographic studies by Huang et al. demonstrated the unique distribution pattern of 5-HT1E receptors in human brain tissue, with particularly high binding in the olfactory bulb and layer IV of the cerebral cortex [@huang].
One of the most significant functional roles of 5-HT1E receptors is their modulatory effect on dopaminergic neurotransmission. Johnson et al. demonstrated that 5-HT1E receptor activation inhibits dopamine release from rat striatal synaptosomes in a concentration-dependent manner [@johnson]. This finding has important implications for:
As an autoreceptor, 5-HT1E modulates serotonin release:
Emerging evidence suggests 5-HT1E receptors modulate other major neurotransmitters:
The high expression of 5-HT1E receptors in the cortex and hippocampus suggests roles in cognitive processes:
Association studies have linked HTR1E polymorphisms with major depressive disorder (MDD). Lùcafe et al. found significant associations between HTR1E genetic variants and MDD susceptibility, particularly in female patients [@lucae]. Additionally, platelet studies from patients with MDD have shown altered 5-HT1E receptor binding characteristics [@kato], suggesting:
Kane et al. investigated the association between HTR1E polymorphisms and bipolar disorder, finding evidence of genetic involvement in disease susceptibility [@kane]. The receptor's modulatory effects on dopamine and serotonin may contribute to the mood dysregulation characteristic of bipolar disorder.
Gaddam et al. comprehensively reviewed the role of 5-HT1E receptors in psychiatric disorders and antipsychotic drug action [@gaddam]. Key findings include:
Gravier et al. explored 5-HT1E receptor agonists as potential antipsychotics with pro-cognitive and anxiolytic effects [@gravier], highlighting:
While direct evidence linking 5-HT1E to Alzheimer's disease pathogenesis is limited, several mechanisms suggest potential involvement:
The 5-HT1E receptor's modulation of dopamine release is particularly relevant to Parkinson's disease:
| Condition | Potential 5-HT1E Involvement |
|---|---|
| Huntington's disease | Striatal signaling modulation |
| Amyotrophic lateral sclerosis (ALS) | Motor neuron excitability |
| Frontotemporal dementia | Serotonergic dysfunction |
The 5-HT1E receptor remains a challenging but promising therapeutic target:
Challenges:
Opportunities:
Several approaches are being explored:
| Application | Rationale |
|---|---|
| Treatment-resistant depression | Novel mechanism targeting different pathways |
| Cognitive deficits in schizophrenia | Pro-cognitive effects demonstrated in preclinical models |
| Bipolar depression | Dopamine and serotonin modulation |
| Parkinson's disease psychosis | Modulation of dopaminergic hyperactivity |
| Anxiety disorders | Anxiolytic effects without sedation |
| Tool | Application |
|---|---|
| [125I]DOI | Radioligand binding studies |
| LY334370 | Selective 5-HT1E agonist (human) |
| ER-20 | 5-HT1E antagonist |
| BRL54443 | 5-HT1E/1F agonist |
The 5-HT1E receptor neuron page connects to several other NeuroWiki topics:
Serotonin 5-HT1E Receptor Neurons represent a unique and fascinating population within the serotonergic system. Despite initial classification challenges, these neurons have emerged as important modulators of neurotransmitter release, cognitive function, and emotional processing. The receptor's distinctive signaling properties, including dual G protein coupling and brain region-specific expression patterns, make it an attractive target for drug development in neuropsychiatric and neurodegenerative disorders. While significant research challenges remain, particularly regarding species differences and pathway-selective drug design, the 5-HT1E receptor offers promising therapeutic potential for conditions ranging from treatment-resistant depression to cognitive deficits in schizophrenia. Continued research into the basic biology and pharmacology of these neurons will be essential for translating this potential into clinical benefits.